Breast cancer is the most common form of cancer across the world and common risk factors for the disease include age, genetic mutations, personal and family history of breast and ovarian cancer, having dense…
Continue Reading
Lunit and Leeds Teaching Hospitals NHS Trust are launching the world’s first prospective study of AI-powered breast screening in symptomatic clinics, using Lunit INSIGHT MMG. This innovative initiative aims to improve breast cancer detection,…
Continue Reading
Lunit’s AI-powered solution, SCOPE IO, is transforming breast cancer care by improving the assessment of tumor-infiltrating lymphocytes (TILs). In a groundbreaking study, SCOPE IO demonstrated remarkable concordance with pathologists’ evaluations, reducing discordant cases significantly….
Continue Reading
By Shania Kennedy
September 19, 2023 – The diagnostic performance of a commercially available artificial intelligence (AI) algorithm was comparable with that of human readers of mammograms, according to a study published recently in Radiology.
Screening mammograms…
What You Should Know:
Ibex Medical Analytics launches Galen Breast HER2™, a novel breast cancer AI-powered biomarker scoring solution developed in collaboration with AstraZeneca and Daiichi Sankyo, to support improved patient outcomes.Galen Breast HER2 is an AI-powered biomarker…
Continue Reading
Researchers at MIT have developed a wearable ultrasound system that is intended to allow women at high risk of breast cancer to perform an ultrasound scan on themselves at home, and may also let…
Continue Reading
Health technology company PicnicHealth announced it is moving into the oncology space and teaming up with AstraZeneca to build a registry to generate real-world data on breast cancer. The company says it will work with…
Continue Reading
By Sara Heath
August 17, 2023 – Hispanic or Latina women get diagnosed with breast cancer at a younger age than their counterparts of other races, but that’s not because of more habitual breast cancer screening…
Continue Reading
iCAD and Google Health are intensifying their partnership to integrate advanced AI technology into the ProFound Breast Health Suite for 2D Mammography. This collaboration aims to facilitate independent reading for breast cancer screening worldwide,…
Continue Reading
What You Should Know:
iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it signed an amendment to its development and commercialization agreement with Google Health, which will…
Continue Reading
